throbber
Published on Web 02/24/2004
`
`Physicochemical Properties of Mixed Micellar Aggregates
`Containing CCK Peptides and Gd Complexes Designed as
`Tumor Specific Contrast Agents in MRI†
`Antonella Accardo,‡ Diego Tesauro,‡ Paola Roscigno,§ Eliana Gianolio,^
`Luigi Paduano,§ Gerardino D’Errico,§ Carlo Pedone,‡ and Giancarlo Morelli*,‡
`Contribution from the Centro InteruniVersitario per la Ricerca sui Peptidi BioattiVi (CIRPeB) &
`Department of Biological Chemistry,UniVersity of Naples “Federico II” Via Mezzocannone,
`6 Naples, I-80134, Italy, Department of Chemistry, UniVersity of Naples “Federico II”
`Via Cynthia, Naples, I-80126, Italy, and Department of Chemistry IFM,UniVersity of Turin,
`Via Giuria, 7 Turin, I-10125, Italy
`
`Received October 23, 2003; E-mail: morelli@chemistry.unina.it
`
`Abstract:New amphiphilic molecules containing a bioactive peptide or a claw moiety have been prepared
`in order to obtain mixed micelles as target-specific contrast agents in magnetic resonance imaging. The
`first molecule, C18H37CONH(AdOO)2-G-CCK8 (C18CCK8), contains a C18 hydrophobic moiety bound to
`the C-terminal cholecystokinin octapeptide amide (CCK 26-33 or CCK8). The second amphiphilic
`compound, C18H37CONHLys(DTPAGlu)CONH2 (C18DTPAGlu) or its gadolinium complex, (C18DTPAGlu-
`(Gd)), contains the same C18 hydrophobic moiety bound, through a lysine residue, to the DTPAGlu chelating
`agent. The mixed aggregates as well as the pure C18DTPAGlu aggregate, in the presence and absence
`of Gd, have been fully characterized by surface tension measurements, FT-PGSE-NMR, fluorescence
`quenching, and small-angle neutron scattering measurements. The structural characterization of the mixed
`aggregates C18DTPAGlu(Gd)-C18CCK8 indicates a spherical arrangement of the micelles with an external
`shell of (cid:24)21 Å and an inner core of (cid:24)20 Å. Both the DTPAGlu(Gd) complexes and the CCK8 peptides
`point toward the external surface. The measured values for relaxivity in saline medium at 20 MHz proton
`Larmor frequency and 25 (cid:176)C are 18.7 mM -1 s-1. These values show a large enhancement in comparison
`with the isolated DTPAGlu(Gd) complex.
`
`Introduction
`
`The more promising medical diagnostic imaging procedures
`currently in use are based on nuclear medicine ((cid:231)-scintigraphy
`and positron emission tomography, PET) and magnetic reso-
`nance imaging (MRI) techniques. The critical point for these
`techniques is that both require a different amount of reporter
`compounds (contrast agents) to be accumulated in the area of
`interest.1,2 In fact, contrast agents help to discriminate between
`
`† Abbreviations: AdOO, 8-amino-3,6-dioxaoctanoic acid; Boc, tert-
`butoxycarbonyl; tBu, tert-butyl; C12E5, polyoxyethylene-5-lauryl ether;
`CCK, cholecystokinin; CCK8, C-terminal octapeptide of cholecystokinin;
`CCKA-R, CCKB-R, cholecystokinin receptor types A and B; cmc, critical
`micellar concentration; DCM, dichloromethane; DIPEA, N,N-diisopropy-
`lethylamine; DMF, N,N-dimethylformamide; DMSO, dimethyl sulfoxide;
`DOTA, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; DpyCl,
`dodecylpyridinium chloride; DTPAGlu, N,N-bis[2-[bis(carboxyethyl)amino]-
`ethyl]-L-glutamic acid; EDT, ethanedithiol; Fmoc, 9-fluorenylmethoxycar-
`bonyl; FT-PGSE-NMR, Fourier transform pulsed gradient spin-echo nuclear
`magnetic resonance; GPCR, G-protein coupled receptor; HATU, O-(7-
`azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium; HOBt, 1-hydroxybenzo-
`triazole; ICP,
`inductively coupled plasma; MRI, magnetic resonance
`imaging; Mtt, 4-methyltrityl; NMRD, nuclear magnetic relaxation dispersion;
`PyBop, benzotriazol-1-yl-oxytris(pyrrolidino)phosphonium; Rt, retention
`time; SANS, small-angle neutron scattering; TFA, trifluoroacetic acid; TIS,
`triisopropylsilane; TMS, tetramethylsilane.
`‡ Department of Biological Chemistry, University of Naples.
`§ Department of Chemistry, University of Naples.
`^ Department of Chemistry IFM, University of Turin.
`
`10.1021/ja039195b CCC: $27.50 © 2004 American Chemical Society
`
`normal and pathological regions. The quantity of reporter
`compound to be accumulated in the area of interest strongly
`varies between these imaging techniques. While the very
`sensitive nuclear medicine techniques require very low tissue
`concentration (10-10 M) of radionuclide to give diagnostically
`significant, low resolved images, MRI gives very resolved
`images but, due to its very low sensitivity, needs higher
`concentration (10-4 M) of contrast agents such as paramagnetic
`Gd(III) complexes. To reach the required local concentration
`of the contrast agent, many carriers have been developed such
`as liposomes3 and other microparticulates,4 micelles,5 dendrim-
`ers,6 linear polymers,7,8 proteins,9 or peptides,10 all of these
`derivatized with the metal complex of interest. Among these
`
`(1) Weissleder, R.; Mahmood, U. Mol. Imaging Radiol. 2001, 219, 316.
`(2) Aime, S.; Cabella, C.; Colombatto, S.; Geninatti Crich, S.; Gianolio, E.;
`Maggioni, F. J. Magn. Reson. Imaging 2002, 16, 394.
`(3) Glogard, C.; Stensrud, G.; Hovland, R.; Fossheim, S. L.; Klaveness, J. Int.
`J. Pharm. 2002, 233, 131.
`(4) Morel, S.; Terreno, E.; Ugazio, E.; Aime, S.; Gasco, M. R. Eur. J. Pharm.
`Biopharm. 1998, 45, 157.
`(5) Anelli, P. L.; Lattuada, L.; Lorusso, V.; Schneider, M.; Tournier, H.; Uggeri,
`F.; Magn. Reson. Mater. Phys., Biol. Med. 2001, 12, 114.
`(6) Wiener, E. C.; Brechbiel, M. W.; Brothers, H.; Magin, R. L.; Gansow, O.
`A.; Tomalia, D. A.; Lauterbur, P. C. Magn. Reson. Med. 1994, 3, 1.
`(7) Aime, S.; Botta, M.; Garino, E.; Geninatti Crich, S.; Giovenzana, G.;
`Pagliarin, R.; Palmisano, G.; Sisti, M. Chem. Eur. J. 2000, 6, 2609.
`(8) Bligh, S. W.; Harding, C. T.; Sadler, P. J.; Bulman, R. A.; Bydder, G. M.;
`Pennock, J. M.; Kelly, J. D.; Latham, I. A.; Marriott, J. A. Magn. Reson.
`Med. 1991, 17, 516.
`J. AM. CHEM. SOC. 2004, 126, 3097-3107 9 3097
`
`MPI EXHIBIT 1094 PAGE 1
`
`MPI EXHIBIT 1094 PAGE 1
`
`

`

`A R T I C L E S
`
`Accardo et al.
`
`Figure1. Schematic representation of mixed micellar aggregates.
`
`carriers, micellar aggregates, formed by amphiphilic molecules
`and structurally constituted by a hydrophobic core and a
`hydrophilic shell, have recently drawn much attention owing
`to their easily controlled properties and good pharmacological
`characteristics.11 For example,
`the self-assembling micellar
`organization of Gd(III)(DOTA) complex derivatized with a
`liphophilic tail allows obtaining a high relaxivity MRI contrast
`agent.12
`There is an increasing interest in developing new contrast
`agents with enhanced properties. First, the new contrast agents
`should have high contrast activity of the metal complex. This
`is critical for MRI applications: high relaxivity of the para-
`magnetic Gd complexes allows reducing the very high concen-
`tration of the reporter compound to be realized in the area of
`interest. Second, the new contrast agents should be selective
`for a specific target: this property allows addressing the reporter
`compound only to the targets, such as membrane receptors
`overexpressed by cancer cells. Therefore, the total amount of
`the contrast agent to be injected for diagnostic analysis could
`this result is very important in (cid:231)-scintigraphy in
`be reduced:
`which radioactive isotopes are used.
`This paper is concerned with the development of new contrast
`agents based on mixed micelles that fulfill both these properties.
`The basic idea behind the new contrast agents is that the two
`different monomers synthesized, one of which contains a
`bioactive molecule able to address the aggregates on the specific
`biological target and the other containing a chelating moiety
`able to form stable complexes with the metal of interest, and
`both presenting also a lipophilic tail, could self-assemble with
`each other in a mixed micelle. The hydrophobic chains allow
`
`the monomers to form mixed micelles, leaving the hydrophilic
`heads on the surface of the aggregates available for the
`appropriate task. In Figure 1 is reported a schematic representa-
`tion of the mixed micellar structure formed in aqueous solution
`by the two monomers. The first monomer C18H37CONH(AdOO)2-
`G-CCK8 (C18CCK8) contains a C18 hydrophobic moiety bound
`to the C-terminal cholecystokinin octapeptide amide (CCK 26-
`33 or CCK8).13 Moreover, to ensure that the bioactive peptide
`remains on the external surface of the micelle when the
`aggregate is formed, two oxoethylene linkers and a glycine
`residue were introduced between the lipophilic tail and the
`CCK8 peptide. The choice of the CCK8 peptide is based on
`the knowledge that this peptide displays high affinity for both
`cholecystokinin receptors, CCKA-R and CCKB-R.14 These
`receptors belong to the G-protein coupled receptors (GPCRs)
`superfamily and are localized in the cell membrane. Both
`CCKA-R and CCKB-R are very promising targets for specific
`contrast agents due to their overexpression in many tumors:
`CCKA-R is overexpressed in pancreatic cancer and CCKB-R is
`found in small cell lung cancer, colon, and gastric cancers,
`medullary thyroid carcinomas, astrocitomas, and stromal ovarian
`tumors.15
`The second monomer, C18H37CONHLys(DTPAGlu)CONH2
`(C18DTPAGlu), or its gadolinium complex (C18DTPAGlu(Gd)),
`contains the same C18 hydrophobic moiety bound, through a
`lysine residue, to the DTPAGlu as chelating agent.16 This
`monomer has been designed to keep the chelating agent on the
`external surface of the mixed micelle. The chelating moiety
`could complex radioactive metal isotopes such as 111In(III) for
`application of the mixed micelles as reporter compounds in
`
`(9) Schmiedl, U.; Ogan, M.; Paajanen, H.; Marotti, M.; Crooks, L.; Brito, E.;
`Brasch, R. C. Radiology 1987, 162, 205.
`(10) Liu, S.; Edward, D. S. Chem. ReV. 1999, 99, 2235.
`(11) Torchilin, V. P. AdV. Drug DeliVery 2002, 54, 235.
`(12) Andre, J. P.; Toth, E.; Fischer, H.; Seelig, A.; Macke, H. R.; Merbach, A.
`E. Chem. Eur. J. 1999, 5, 2977.
`
`(13) Silvente-Poirot, S.; Dufresne, M.; Vaysse, N.; Fourmy, D. Eur. J. Biochem.
`1993, 215, 513.
`(14) Wank, S. A. Am. J. Physiol. 1995, 269, G628.
`(15) Reubi, J. C.; Schaer, J. C.; Waser, B. Cancer Res. 1997, 57, 1377.
`(16) Anelli, P. L.; Fedeli, F.; Gazzotti, O.; Lattuada, L.; Lux, G.; Rebasti, F.
`Bioconjugate Chem. 1999, 10, 137.
`
`3098 J. AM. CHEM. SOC. 9 VOL. 126, NO. 10, 2004
`
`MPI EXHIBIT 1094 PAGE 2
`
`MPI EXHIBIT 1094 PAGE 2
`
`

`

`Mixed Micellar Aggregates as Contrast Agents
`
`A R T I C L E S
`
`diagnostic (cid:231)-scintigraphy, or paramagnetic ions such as Gd-
`(III) for application as contrast agent in MRI. A DTPAGlu-
`CCK8 conjugate has been recently used to give in vitro and in
`vivo very stable complexes with the radioactive isotope 111In-
`(III),17 while Gd(III) complexes of DTPAGlu and of DTPAGlu-
`CCK8 conjugate have been completely characterized for both
`their stability and relaxometric properties.18 The supramolecular
`aggregation of the C18DTPAGlu(Gd) complexes in the mixed
`micelle gives rise to a slow rotation and, consequently, increases
`the proton relaxivity with respect to that shown by monomeric
`Gd(III)-chelate complexes.12 Finally,
`the presence in the
`micelles of two separate monomers gives the unique opportunity
`to tune the ratio between the two active components in order to
`find the right compromise between the number of bioactive
`peptides on the micellar surface to address the micelle on the
`target receptors and the number of the metal-chelate complexes
`able to give high contrast activity of the supramolecular adduct.
`In this paper we present a complete physicochemical char-
`acterization of mixed micelles formed in aqueous solution by
`the two monomers C18CCK8 and C18DTPAGlu in the presence
`or in the absence of a nonionic surfactant (polyoxyethylene-5-
`lauryl ether, C12E5) used to stabilize the micelle formation.
`Moreover, the mixed micelles containing Gd(III) ions complexed
`by the chelating DTPAGlu agent have been studied for their
`relaxometric behavior in view of their use as CCK receptor
`specific contrast agents for MRI applications.
`
`Materials and Methods
`
`Materials. Protected NR-Fmoc-amino acid derivatives, coupling
`reagents, and Rink amide MBHA resin were purchased from Calbio-
`chem-Novabiochem (Laufelfingen, Switzerland). The Fmoc-8-amino-
`3,6-dioxaoctanoic acid (Fmoc-AdOO-OH) was purchased from Neo-
`system (Strasbourg, France). The DTPAGlu pentaester, N,N-bis[2-
`[bis[2-(1,1-dimethylethoxy)-2-oxoethyl]amino]ethyl]-L-glutamic acid
`1-(1,1-dimethylethyl) ester,16 was provided by Bracco Imaging SpA
`(Milan, Italy) and was used without further purification. For its synthesis
`refer to published methods.16 C12E5 (stated purity >99%) was
`purchased from Sigma-Aldrich (Milwaukee, WI), as reagent grade, and
`it was used without further purification. All other chemicals were
`commercially available by Sigma-Aldrich, Fluka (Bucks, Switzerland),
`or LabScan (Stillorgan, Dublin, Ireland) and were used as received
`unless otherwise stated. The molar mass of the C12E5 surfactant was
`406.60 g mol-1. All solutions were prepared by weight using doubly
`distilled water. Samples to be measured by FT-PGSE-NMR and SANS
`techniques were prepared using heavy water (Sigma-Aldrich, purity
`>99.8%). The pH of all solutions was kept constant at 7.4.
`Chemical Synthesis. Solid phase peptide synthesis was performed
`on a Shimadzu (Kyoto, Japan) Model SPPS-8 fully automated peptide
`synthesizer. Analytical RP-HPLCs were carried out on a Shimadzu 10A-
`LC using a Phenomenex C18 column (Torrance, CA), 4.6 (cid:2) 250 mm,
`eluted with an H2O/0.1% TFA (A) and CH3CN/0.1% TFA (B). Two
`gradients from 60% to 80% B over 10 min at 1 mL/min flow rate and
`from 80% to 95% B over 15 min at 1 mL/min flow rate were used.
`Preparative RP-HPLCs were carried out on a Waters (Milford, MA)
`Model Delta Prep 4000 equipped with a UV lambda-Max Model 481
`detector using a Vydac C18 column (Columbia, MD), 22 (cid:2) 250 mm,
`eluted with an H2O/0.1% TFA (A) and CH3CN/0.1% TFA (B) linear
`gradient at 20 mL/min flow rate. UV-vis spectra were carried out by
`
`(17) Aloj, L.; Carraro, C.; Zannetti, A.; Del Vecchio, S.; Tesauro, D.; DeLuca,
`S.; Panico, M.; Arra, A.; Pedone, C.; Morelli, G.; Salvatore, M. J. Nucl.
`Med. 2004, 45(3), in press.
`(18) Aime, S.; Gianolio, E.; Morelli, G.; Tesauro, D.; De Luca, S.; Anelli, P. L.
`Manuscript in preparation.
`
`using an UV-vis Jasco (Easton, MD) Model 440 spectrophotometer
`with a path length of 1 cm. Mass spectra were carried out on a Maldi-
`tof Voyager-DE Perseptive Biosystem (Framingham, MA) apparatus
`using R-cyano-4-hydroxycinnamic acid as matrix and bovine insulin
`as internal reference. The monodimensional 1H NMR in DMSO-d6
`spectrum was performed on a Varian (Palo Alto, CA) 400 MHz
`spectrometer.
`C18H37CONH(AdOO)2-G-CCK8 (C18CCK8). Peptide synthesis
`was carried out in the solid phase under standard conditions using Fmoc
`strategy. Rink amide MBHA resin (0.78 mmol/g, 0.1 mmol scale, 0.128
`g) was used. The peptide chain was elongated by sequential coupling
`and Fmoc deprotection of the following Fmoc-amino acid derivatives:
`Fmoc-Phe-OH, Fmoc-Asp(OtBu)-OH, Fmoc-Met-OH, Fmoc-Trp(Boc)-
`OH, Fmoc-Gly-OH, Fmoc-Met-OH, Fmoc-Tyr(tBu)-OH, Fmoc-Asp-
`(OtBu)-OH, Fmoc-Gly-OH, and two residues of Fmoc-AdOO-OH. All
`couplings were performed twice for 1 h, by using an excess of 4
`equivalents (equiv) for the single amino acid derivative. The R-amino
`acids were activated in situ by the standard HOBt/PyBop/DIPEA
`procedure.19 DMF was used as a solvent. Fmoc deprotections were
`obtained by 20% solution of piperidine in DMF. Only the two residues
`of Fmoc-AdOO-OH were added in a single coupling by using an excess
`of 2 equiv. When the peptide synthesis was complete, the resin was
`washed and the terminal Fmoc protection removed. To obtain the
`lipophilic monomer, 0.119 g (0.4 mmol) of nonaoctanoic acid were
`coupled on the linker peptide N-terminus by using 0.208 g (0.4 mmol)
`of PyBop, 0.0612 g (0.4 mmol) of HOBt, and 134 (cid:237)L (0.8 mmol) of
`DIPEA in 2 mL of a mixture DMF/DCM ) 1/1. Coupling time was 1
`h under stirring at room temperature.
`The yield for aliphatic acid coupling, monitored by the Kaiser test,
`was in the range 95-98%. For deprotection and cleavage, the fully
`protected resin was treated with TFA containing triisopropylsilane
`(2.0%), ethanedithiol (2.5%), and water (2.5%), and the free product
`precipitated at 0 (cid:176)C by adding ethyl ether dropwise. Purification of the
`crude mixture was carried out by RP-HPLC, Rt ) 21.9 min. Maldi-
`tof-MS confirms the product identity: C18H37CONH(AdOO)2-G-CCK8
`(MW ) 1687), m/z ) 1688.
`C18H37CONHLys(DTPAGlu)CONH2 (C18DTPAGlu). A sample
`of 624.79 mg (1.00 mmol) of Fmoc-Lys(Mtt)-OH activated by 1 equiv
`of PyBop and HOBt and 2 equiv of DIPEA in DMF was coupled to
`Rink amide MBHA resin (0.78 mmol/g, 0.250 mmol scale, 0.320 g),
`with stirring of the slurry suspension for 1 h. The solution was filtered
`and the resin washed with three portions of DMF and three portions of
`DCM. The Mtt protecting group was removed by treatment with 2.0
`mL of DCM/TIS/TFA (94:5:1) mixture.19 The treatment was repeated
`several times until the solution became colorless. The resin was washed
`by DMF and then the DTPAGlu pentaester chelating agent was linked,
`through its free carboxyl function, to the R-NH2 of the lysine residue.
`This coupling step was performed using 2.0 equiv of DTPAGlu
`pentaester and HATU, and 4 equiv of DIPEA in DMF as solvent. The
`coupling time, compared with the classical solid phase peptide synthesis
`protocol, was increased up to 2 h, and the reaction was tested for
`completion by the Kaiser test. After removal of the Fmoc group by
`20% piperidine in DMF,
`the coupling of nonaoctanoic acid was
`performed in a mixture DCM/DMF (1:1) in the previously described
`condition. For deprotection and cleavage, the fully protected fragment
`was treated with TFA containing TIS (2.0%) and water (2.5%). The
`crude product was precipitated at 0 (cid:176) C, washed several times with small
`portions of water, and recrystallized from methanol and water. The
`product was characterized by 1H NMR spectroscopy and Maldi-tof mass
`spectrometry.
`1H NMR (chemical shifts in (cid:228), TMS as internal standard) ) 4.18
`(m, 1H, CH Lys R), 3.80 (overlapped, 1H, CHGlu R), 3.40 (overlapped,
`8H, CH2COOH) 3.02 (t, 2H, CH2 Lys (cid:15)) 2.81 (m, 8H, N-CH2), 2.22
`
`(19) Chang, W. C.; White, P. D. Fmoc solid phase peptide synthesis; Oxford
`University Press: New York, 2000.
`
`J. AM. CHEM. SOC. 9 VOL. 126, NO. 10, 2004 3099
`
`MPI EXHIBIT 1094 PAGE 3
`
`MPI EXHIBIT 1094 PAGE 3
`
`

`

`A R T I C L E S
`
`Accardo et al.
`
`(t, 2H, CH2CO), 2.14 (m, 2H, RCH2CH2CO), 1.87 (m, 1H, CH2 Lys
`(cid:226)), 1.76 (m, 1H, CH2 Lys (cid:226)), 1.65 (m, 1H, CH2 Lys (cid:228)), 1.51 (m, 3H,
`CH2 Lys (cid:231),(cid:228)), 1.42 (t, 2H, RCH2CH2CO), 1.25 (m, 30H, CH2 aliphatic),
`0.90 (t, 3H, CH3). Maldi-tof-MS confirms the product identity: C18H37-
`CONHLys(DTPAGlu)CONH2 (MW ) 870), m/z 871.
`Preparation of Gadolinium Complex, C18DTPAGlu(Gd). The
`complexation has been carried out by adding light excess of the GdCl3
`to the aqueous solution of the C18DTPAGlu ligand at neutral pH and
`room temperature. The formation of Gd complex, C18DTPAGlu(Gd),
`was followed by measuring the solvent proton relaxation rate (1/T1).
`The excess of uncomplexed Gd(III) ions, which yields a variation of
`the observed relaxation rate, was removed by centrifugation of the
`solution brought to pH 10; further relaxation rate measurements were
`made to check the complete Gd(III) ions removal.
`Preparation of Solutions. All solutions were prepared by weighting,
`buffering the samples at pH 7.4 with 0.10 M phosphate and 34 mM
`NaCl. pH measurements were made by using the pH meter MeterLab
`PHM 220. The pH meter was calibrated with standards at pH 7 and
`pH 10. In most cases the samples to be measured were prepared from
`stock solutions. All solutions were stirred at room temperature until
`complete dissolution and then used without further treatment.
`In C18DTPAGlu-C18CCK8-water and C18DTPAGlu-C18CCK8-
`C12E5-water solutions the imposed ratio between the solutes was as
`such to have an average of three peptide derivatives per micelle. This
`has been verified through the SANS measurements, as discussed below.
`In C18DTPAGlu-C12E5-water and C18CCK8-C12E5-water
`ternary systems the imposed ratio between stoichiometric solute
`concentrations was 1:3, and 1:9, respectively.
`Surface tension, fluorescence quenching, and SANS measurements
`were also performed on mixtures where C18DTPAGlu was replaced
`with the Gd complex C18DTPAGlu(Gd).
`Surface Tension Measurements. The surface tension, (cid:231), was
`measured with an accuracy of 0.1 dyn cm-1, by the Du Nouy ring
`method, using a KSV Sigma 70 digital tensiometer, equipped with an
`automatic device to select the rising speed of the platinum ring and to
`set the time lag between two measurements. The temperature was kept
`constant at 25.00 ( 0.01 (cid:176) C. The tensiometer was calibrated with water
`and acetone.20
`Self-Diffusion Measurements. The self-diffusion coefficients were
`measured by the FT-PGSE-NMR technique at 25 (cid:176) C.21 A spectrometer
`operating in the 1H mode at 80 MHz and equipped with a pulsed
`magnetic field gradient unit, made by Stelar (Mede, Pavia, Italy), was
`employed. The temperature was controlled within 0.1 (cid:176)C through a
`variable-temperature controller, Model VTC-87. The expression for
`individual spin-echo peak amplitude for a given line is
`
`A ) A0 exp[-(cid:231)mg
`
`2g2D(cid:228)2(¢ - (cid:228)/3)]
`
`(1)
`
`where A0 is a constant for a specific set of experimental conditions,
`(cid:231)mg is the gyromagnetic ratio of the proton, D is the self-diffusion
`coefficient of the species responsible for the NMR signal, g is the
`magnitude of the applied gradient, and ¢ and (cid:228) are spacing and duration
`of the gradient pulses, respectively. Echo delays were kept constant so
`that the relaxation effect must not be accounted for. Equation 1 was
`fitted by nonlinear least-squares routine to the attenuation of the echo
`amplitude sampled as a function of g.
`Fluorescence Quenching. To evaluate the mean aggregation number
`of surfactants into the micelles, fluorescence quenching measurements
`were performed by a Jasco FP-750 (Easton, MD) spectrofluorimeter
`at 25 (cid:176) C. The fluorescence probe pyrene and the quencher dodecylpy-
`ridinium chloride (DpyCl) have been used in all systems. The excitation
`wavelength was set at 335 nm, and fluorescence intensity was detected
`at 383 nm. This latter wavelength corresponds to the third out of five
`peaks of vibronic fluorescence that the pyrene spectrum exhibits. The
`
`(20) Arai, H.; Murata, M. J. J. Colloid Interface Sci. 1973, 44, 475.
`(21) Stilbs, P. NMR Spectrosc. 1987, 19, 1.
`
`3100 J. AM. CHEM. SOC. 9 VOL. 126, NO. 10, 2004
`
`the
`aggregation numbers were measured in the assumption that
`intramicellar “static” quenching between the probe and the quencher,
`both following Poisson distribution, is dominant. The pyrene concentra-
`tion was 2 (cid:2) 10-6 mol dm-3, and the fluorescence intensity at 383 nm
`was monitored at decreasing amount of the DpyCl quencher starting
`from a molar concentration ratio R ) [quencher]/[micelle] ) [q]/[M]
`(cid:24) 1.22-24
`The fluorescence intensity in the presence of the quencher is given
`
`by
`
`I ) Io exp(-[q]/[M])
`
`(2)
`
`where Io is the fluorescence intensity in the absence of inhibitor. In the
`approximation of the phase separation model the following equation
`holds:
`
`[M] ) (C - cmc)/Nagg
`
`(3)
`
`where C is the concentration of the aggregating species. Hence, the
`aggregation number, Nagg, is obtained from the slope of ln(I/Io) vs [q]/(C
`- cmc).25,26 Due to the very low concentration of the systems studied,
`in eq 3 molarity has been replaced by molality.
`Water Proton Relaxation Measurements. The longitudinal water
`proton relaxation rates were measured on a Stelar Spinmaster (Mede,
`Pavia, Italy) spectrometer operating at 20 MHz, by means of the
`standard inversion-recovery technique (16 experiments, 2 scans). A
`typical 90(cid:176) pulse width was 4 (cid:237)s and the reproducibility of the T1 data
`was (0.5%. The temperature was kept at 25 (cid:176)C with a Stelar VTC-91
`air-flow heater equipped with a copper-constantan thermocouple
`(uncertainty (0.1 (cid:176) C). The proton 1/T1 NMRD profiles were measured
`over a continuum of magnetic field strength from 0.000 24 to 0.28 T
`(corresponding to 0.01-12 MHz proton Larmor frequency) on a Stelar
`Fast Field-Cycling relaxometer. This relaxometer works under complete
`computer control with an absolute uncertainty in 1/T1 of (1%. Data
`points at 20 and 90 MHz were added to the experimental NMRD
`profiles and were recorded on the Stelar Spinmaster (20 MHz) and on
`a JEOL EX-90 (90 MHz) (Tokyo, Japan) spectrometer, respectively.
`1H Water Relaxation Rate. The relaxivity of a Gd(III) complex
`results from contributions arising mainly from water molecules in the
`inner and outer coordination spheres:
`
`) r1
`
`His + r1
`
`r1
`
`Hos
`
`(4)
`
`His refers to the contribution from the exchange of the water protons
`r1
`in the first coordination sphere of the paramagnetic metal ion:
`
`His )
`
`r1
`
`nw[C]
`+ (cid:244)M)
`55.6(T1M
`
`(5)
`
`where nw is the hydration number, [C] is the molar concentration of
`the paramagnetic chelate, T1M is the longitudinal relaxation time of the
`inner sphere water protons, and (cid:244)M is their residence lifetime.
`Hos, describes the contribution from water
`The outer sphere term, r1
`molecules which diffuse around the paramagnetic complex (bulk
`solvent).
`The complex theory that governs the relaxation process in a
`paramagnetic chelate is well described by the models developed by
`Solomon-Bloembergen-Morgan for what concerns the inner sphere
`contribution and by Hwang and Freed for the outer sphere one.27
`Small-Angle Neutron Scattering. SANS measurements were
`performed at 25 (cid:176)C on the KWS2 located at the Forschungszentrum
`
`(22) Infelta, P. P.; Gratzel, M.; Thomas, J. K. J. Phys. Chem. 1975, 78, 190.
`(23) Tachiya, M. Chem. Phys. Lett. 1975, 33, 289.
`(24) Gehlen, M. H.; De Schryver, F. C. Chem. ReV. 1993, 93, 199.
`(25) Turro, N. J.; Yekta, A. J. Am. Chem. Soc. 1978, 100, 5951.
`(26) McNeil, R.; Thomas, J. K. J. Colloid Interface Sci. 1981, 83, 57.
`(27) Banci, L.; Bertini, I.; Luchinat, C. Nuclear and Electronic Relaxation;
`VCH: Weinheim, 1991; p 91.
`
`MPI EXHIBIT 1094 PAGE 4
`
`MPI EXHIBIT 1094 PAGE 4
`
`

`

`Mixed Micellar Aggregates as Contrast Agents
`
`A R T I C L E S
`
`Julich, Germany. Neutrons with an average wavelength of 7 Å and
`wavelength spread ¢(cid:236)/(cid:236) < 10% were used. A two-dimensional array
`detector at two different sample-to-detector distances, 2 and 8 m,
`detected neutrons scattered from the sample. These configurations
`allowed collecting the scattered intensity in a range of moment transfer
`Q between 0.003 and 0.12 Å-1. Samples were contained in 1 mm path
`length quartz cells, and measurement times ranged between 20 min
`and 2 h. The data were then corrected for background, empty cell, and
`solvent contribution, and then reduced to scattering cross section (in
`absolute units per centimeter), following the standard procedure.28
`Method of Data Analysis. The general scattering intensity, contain-
`ing information about shape, size, and interactions of monodisperse
`scattering bodies, is given by29
`
`I(Q) ) Nb ((cid:229)
`
`i
`
`- Vb
`
`F
`
`s)2P(Q) S(Q) + Iinc
`
`bi
`
`(6)
`
`The CCK8 peptide was synthesized as previously described.32
`At the Asp N-terminal residue of the CCK8 peptide a glycine
`residue and two units of 8-amino-3,6-dioxaoctanoic acid were
`added directly on the solid phase. As a final step, the nonaoc-
`tanoic acid was bound to the N-terminal position of the peptide
`derivative. The cleavage of resin and the deprotection of the
`side chain functions were performed in a TFA/TIS/EDT/water
`mixture. The peptide derivative was isolated in good yields and
`purified by RP-HPLC. The analitycal data (Maldi-tof mass
`spectrum and RP-HPLC) confirm compound identity and purity.
`The two units of the hydrophilic linker increase the affinity for
`the polar solvent of the peptide moiety.
`The amphiphilic chelating moiety C18DTPAGlu was also
`synthesized in the solid phase using a resin support. Fmoc-Lys-
`(Mtt)-OH was anchored to the resin and the side chain was
`selectively deprotected. Then, DTPAGlu pentaester, the chelat-
`ing agent fully protected by tert-butyl (tBu) groups on its
`carboxyl functions with the exception of the carboxyl group on
`the side chain of L-glutamic acid, was linked, by a single
`coupling step, to the (cid:15)-NH2 amino function of the lysine residue.
`Successively, the Fmoc protecting group was removed by the
`R-NH2 amino function of the lysine residue and the nonaoc-
`tanoic acid was bound. After cleavage from the resin the product
`was characterized by 1H NMR spectroscopy and Maldi-tof mass
`spectrometry.
`Surface Tension. The surface tension was measured on
`C12E5-water, C18DTPAGlu-water, and C18CCK8-water
`binary systems; on C18DTPAGlu-C12E5-water, C18CCK8-
`C12E5-water, and C18DTPAGlu-C18CCK8-water ternary
`systems; and on C18DTPAGlu-C18CCK8-C12E5-water
`quaternary system. The surfactant concentration was raised well
`above the expected critical micellar concentration, cmc. Surface
`tension measurements were also performed on all systems once
`C18DTPAGlu was replaced by C18DTPAGlu(Gd).
`All the above systems show a concentration dependence of
`the surface tension, (cid:231), typical of systems containing amphiphilic
`molecules that form micelles. Addition of solute to pure water
`((cid:231)o ) 72.0 dyn cm-1) has the effect of decreasing (cid:231) to the cmc
`value, at which the surface tension curve changes its slope and
`approaches a constant value. However, there are significant
`differences among the systems studied, as inspection of Table
`1 suggests. For the C18CCK8-water system the typical change
`in the slope of the (cid:231) vs ln m curve, of micellar systems, has not
`been observed.
`Binary Systems: C18DTPAGlu-Water, C18CCK8-
`Water, and C12E5-Water. In Figure 2 the surface tension
`diagram of the C18DTPAGlu-water and C12E5-water binary
`systems along with C18DTPAGlu(Gd)-water system are
`reported. The cmc values detected for the C18DTPAGlu-water
`and C12E5-water systems are about the same, 5 (cid:2) 10-5 and
`4 (cid:2) 10-5 mol kg-1 respectively, although the limit value of the
`surface tension for the two systems is quite different. This is to
`be assigned to the higher hydrophobic contribution of C12E5
`to the surface composition with respect to the other compounds
`studied in this paper.
`The behavior of C18DTPAGlu(Gd)-water is substantially
`similar to that of the corresponding system in the absence of
`
`(32) Ragone, R.; De Luca, S.; Tesauro, D.; Pedone, C.; Morelli, G. Biopolymers
`2001, 56, 47.
`
`J. AM. CHEM. SOC. 9 VOL. 126, NO. 10, 2004 3101
`
`where Nb is the number density of scattering bodies, Vb is the volume
`of each scattering particle, (cid:229)
`ibi is the sum of the scattering lengths
`over the atoms constituting the body, and Fs is the solvent scattering
`length density. P(Q) and S(Q) are the form factor and structure factor,
`respectively. Iinc is the incoherent scattering cross section.
`The form factor contains information on the shape of the scattering
`objects, whereas the structure factor S(Q) accounts for interparticle
`correlations and is normally important for concentrated or charged
`systems.
`The structure of micelles present in the systems under study has
`been established by analyzing the scattering data through eq 6, imposing
`that the number density of scattering bodies and their volume are Nb
`) (C - cmc)La/Nagg and Vb ) NaggVm, where C is the stoichiometric
`solute concentration, Vm is the volume of the free surfactant, Nagg is
`the aggregation number of the micelles, and La is Avogadro’s constant.29
`The micelles were modeled as a spherical “core + shell”, and hence
`the form factor P(Q) is reduced to a sum of two Bessel first-order
`spherical functions:29
`
`P(Q) )(f
`
`3j1(u1)
`u1
`
`+ (1 - f)
`
`3j1(u2)
`u2
`
`)2
`
`(7)
`
`(8)
`
`(9)
`
`(10)
`
`(11)
`
`with
`
`) Qa
`
`u1
`) Q(a + d)
`
`u2
`
`f )
`
`Vf(F
`
`1
`
`- F
`2)
`
`(bi
`
`- Vm
`
`F
`
`s)
`
`i
`
`j1(x) ) sin x - x cos x
`x2
`
`Vf is the micelle core volume; a and d are the radius of the core and
`the thickness of the hydrophilic shell, respectively. F1 and F2 are the
`densities of scattering length of the core and shell.
`The structure factor, S(Q), can be calculated through the Hayter and
`Penfold theory.30,31
`
`Results
`
`Synthesis of Monomers. The peptide synthesis was per-
`formed by the solid phase approach using Fmoc/tBu chemistry.
`
`(28) Berti, D.; Pini, F.; Baglioni, P.; Teixeira, J. J. Phys. Chem. B 1999, 103,
`1738.
`(29) Hayter, J. B.; Penfold, J. J. Colloid Polym. Sci. 1983, 261, 1072.
`(30) Hayter, J. B.; Penfold, J. Mol. Phys. 1991, 42, 109.
`(31) Hayter, J. B.; Hansen, J. B. Mol. Phys. 1991, 42, 651.
`
`MPI EXHIBIT 1094 PAGE 5
`
`MPI EXHIBIT 1094 PAGE 5
`
`(cid:229)
`

`

`A R

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket